Ophthalmology · Brooklyn, NY
NPI
1508021494
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
244 86th St # 1
Brooklyn, NY, 11209
Phone (718) 238-3438
Groups this clinician bills Medicare through
Medicare paid, 2024
$332K
4,527 services
Medicare patients, 2024
624
Average age 75
Drug cost, 2024
$1.2M
8,890 prescriptions
Company payments, 2025
$664
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abraham K Sleem was code 92286 (standard x-ray), 571 times for 473 patients. In total Abraham K Sleem billed 4,527 services in 41 codes, and Medicare paid $332K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92286 Standard X-ray | Office | 571 | 473 | $35.17 | $20K |
| 92014 Ophthalmological E&M | Office | 512 | 406 | $116.94 | $60K |
| 68761 Eye | Office | 438 | 170 | $105.96 | $46K |
| 92020 Ophthalmological E&M | Office | 418 | 345 | $26.14 | $11K |
| 92134 Computerized Ophthalmic Imaging | Office | 342 | 293 | $35.30 | $12K |
| 92250 Angiography | Office | 288 | 251 | $31.78 | $9,152 |
| 92201 Ophthalmological E&M | Office | 286 | 266 | $23.55 | $6,735 |
| 92083 Vision, Hearing, and Speech Services | Office | 269 | 214 | $60.65 | $16K |
| 76512 Ultrasound - Nonspecific | Office | 190 | 93 | $43.79 | $8,320 |
| 76514 Ultrasound - Nonspecific | Office | 169 | 146 | $10.38 | $1,754 |
| 99213 Office E&M - Established | Office | 161 | 103 | $86.43 | $14K |
| 92004 Ophthalmological E&M | Office | 132 | 132 | $135.51 | $18K |
| 92133 Computerized Ophthalmic Imaging | Office | 120 | 107 | $32.43 | $3,891 |
| 92136 Ultrasound - Nonspecific | Office | 115 | 115 | $42.08 | $4,840 |
| 92202 Ophthalmological E&M | Office | 100 | 94 | $14.79 | $1,479 |
By year: 2022 $230K for 2,753 services; 2023 $276K for 3,626 services; 2024 $332K for 4,527 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abraham K Sleem prescribed most often to Medicare patients was Azelastine Hcl, with 1,881 prescriptions and refills. In total Abraham K Sleem wrote 8,890 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 1,881 | 1,966 | 273 | $16K |
| Latanoprost Generic | 1,101 | 1,728 | 215 | $9,168 |
| Erythromycin Erythromycin Base | 932 | 949 | 213 | $14K |
| Prednisolone Acetate Generic | 823 | 1,119 | 307 | $38K |
| Ofloxacin Generic | 506 | 626 | 261 | $9,948 |
| Ketorolac Tromethamine Generic | 473 | 576 | 214 | $13K |
| Cromolyn Sodium Generic | 461 | 500 | 66 | $6,358 |
| Restasis Cyclosporine | 380 | 613 | 81 | $374K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 293 | 542 | 69 | $5,194 |
| Brimonidine Tartrate Generic | 220 | 325 | 55 | $6,940 |
| Timolol Maleate Generic | 191 | 299 | 40 | $4,019 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 176 | 186 | 90 | $2,464 |
| Vyzulta Latanoprostene Bunod | 160 | 213 | 34 | $59K |
| Xiidra Lifitegrast | 156 | 302 | 53 | $201K |
| Cyclosporine Generic | 98 | 190 | 36 | $48K |
Brand drugs: - claims; generic drugs: 6,222 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abraham K Sleem $664 ($664 in general payments such as food, travel and fees) from 9 companies. The largest payer was Bausch & Lomb Americas Inc. with $159.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 9 | $159 |
| Tarsus Pharmaceuticals, Inc. TARS | 7 | $139 |
| Dompe US, Inc. | 4 | $108 |
| Alcon Vision LLC ALC | 3 | $85.37 |
| Oyster Point Pharma, Inc. | 3 | $65.34 |
| Abbvie Inc. ABBV | 2 | $35.43 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $24.04 |
| Harrow Eye, LLC | 1 | $23.94 |
| Biotissue Holdings Inc. | 1 | $23.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.